To combat heart disease, health innovators are focusing on making healthcare institutions more trustworthy to the needs of ...

Professor Raphael Nyarkotey Obu, a Naturopathic healthcare expert, is spearheading efforts to promote hibiscus (locally known as sobolo) as ...

Researchers have published findings from the phase 2 LITESPARK-003 study of patients with previously untreated advanced clear ...

The deal could help funnel eligible patients towards Teladoc’s other offerings, including chronic condition management ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Recent research reported that women with endometriosis have an approximately 20% increased risk for stroke and a 35% greater risk for heart attack compared with women without endometriosis. Although ...

Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...

Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

Researchers at the Smidt Heart Institute at Cedars-Sinai have found that women with type 2 diabetes who are diagnosed with ...

Patients with axSpA and early-stage hypertension face elevated risks for CVEs, likely due to their high inflammatory burden.